Navigation Links
Venereal Cancer in Dogs Transmitted by Contagious Cancer Cells
Post Your Comments:
(Date:9/5/2008)...hat triggers them, experts say , , FRID...the 36 million Americans who suffer from seasonal ...hat is free from pollen and other allergens this f... happen in the spring, they can be bothersome in o...nging cities to live in are Greensboro, N.C., Gree...
(Date:9/5/2008).../ -- Speaker Nancy Pelosi,issued the following sta...Up to Cancer" telethon, to be aired on all network... who has not seen a loved one,suffer because of ca... each,year there are more than 1.4 million new cas...cating the scourge of cancer a national priority o...
(Date:9/5/2008)...n Saturday, September 6, PARI,Respiratory Equipmen...y,s,Family as part of their "Breathe Easier" serie... company that provides patients, such as COPD,suff...hat deliver needed,medications directly to the lun... affected by respiratory,diseases and those who ca...
(Date:9/5/2008).../ -- As the general election,campaign begins in ea...t,Business ( http://www.nfib.com ) is looking to t... on the healthcare concerns of small,business. Now...e over, NFIB,is asking both candidates to fully co...sinesses as they further develop their healthcare ...
Breaking Medicine News(10 mins):Health News:No Place Safe From Allergies 2Health News:PARI Respiratory Equipment Featured on Oxygen Network 2Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 2Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 3
...e February issue of the American Naturalist is the...ly// to eat their offspring when they have been cu...stic decision a father can make is to cannibalize ...(Ph.D. candidate at Simon Fraser University), Lawr...
...tracting tuberculosis, especially those in their 2... excessive weight loss, according to a report. L...were people in their 20s. According to the repor...isease Control and Prevention, 41,950 people contr...
...rheumatoid arthritis are autoimmune diseases, whic...tem// to check itself. Researchers are still unsu... which are responsible for weakening the immune sy...he Whitehead Institute and the Dana-Farber Cancer ...
... late twenties group who take the preventive test ... percentage has come down to 69.4 in 2005-06 from ...n in mid thirties group too. Women are said to av...asive procedures of the same. But according to th...
Other Medicine News:Health News:More Youngsters Get Tuberculosis 2Health News:Understanding Autoimmune Disease 2
(Date:9/4/2008)...hed in ,The Lancet, and Presented at ESC Congress-...rom a new international,study, the GISSI Heart Fai...mega-3 acid ethyl esters reduced all cause mortali...ons in patients with chronic heart,failure. These ...on of ,The,Lancet, and were presented at the Europ...
(Date:9/4/2008)...s to Enroll 750 Women at More Than 100 Sites in th... QuatRx Pharmaceuticals, a,privately-held biopharm...rcialization of compounds to treat endocrine, meta...d that it has initiated a second,Phase 3 clinical ...any,s,estrogen-free oral therapy in development fo...
(Date:9/4/2008)...onstrates potent antiviral activity and favorable ...AMBRIDGE, Mass., Sept. 4 /-...biopharmaceutical company engaged,in the discovery...an viral,and other infectious diseases, today anno...tudy evaluating IDX899, a non-nucleoside reverse,t...
(Date:9/3/2008)...ia, Sept. 4 /Xinhua--,Pharm...L) today announced,that it has enrolled the first ...rial evaluating Bronchitol in cystic fibrosis suff...1 hospitals across North,America, Argentina and Ge...axis seeks approval to market Bronchitol for cysti...
Breaking Medicine Technology:New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 2Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 3Leading Lobbying Firm Celebrates Growth and New Name 3A Troutman Sanders Strategies 6702 1Leading Lobbying Firm Celebrates Growth and New Name 3A Troutman Sanders Strategies 6702 2Paying to save tropical forests could be a way to reduce global carbon emissions 4180 1Paying to save tropical forests could be a way to reduce global carbon emissions 4180 2Paying to save tropical forests could be a way to reduce global carbon emissions 4180 3Paying to save tropical forests could be a way to reduce global carbon emissions 4180 4Varian Inc Reports Third Quarter 2008 Results 6697 1Varian Inc Reports Third Quarter 2008 Results 6697 2Varian Inc Reports Third Quarter 2008 Results 6697 3Varian Inc Reports Third Quarter 2008 Results 6697 4Varian Inc Reports Third Quarter 2008 Results 6697 5Varian Inc Reports Third Quarter 2008 Results 6697 6Varian Inc Reports Third Quarter 2008 Results 6697 7Varian Inc Reports Third Quarter 2008 Results 6697 8Varian Inc Reports Third Quarter 2008 Results 6697 9Varian Inc Reports Third Quarter 2008 Results 6697 10Varian Inc Reports Third Quarter 2008 Results 6697 11Varian Inc Reports Third Quarter 2008 Results 6697 12Varian Inc Reports Third Quarter 2008 Results 6697 13Varian Inc Reports Third Quarter 2008 Results 6697 14Varian Inc Reports Third Quarter 2008 Results 6697 15Varian Inc Reports Third Quarter 2008 Results 6697 16Varian Inc Reports Third Quarter 2008 Results 6697 17Varian Inc Reports Third Quarter 2008 Results 6697 18Varian Inc Reports Third Quarter 2008 Results 6697 19Varian Inc Reports Third Quarter 2008 Results 6697 20Varian Inc Reports Third Quarter 2008 Results 6697 21Varian Inc Reports Third Quarter 2008 Results 6697 22Varian Inc Reports Third Quarter 2008 Results 6697 23Varian Inc Reports Third Quarter 2008 Results 6697 24Varian Inc Reports Third Quarter 2008 Results 6697 25Human Genome Sciences to Sponsor Conference Call to Discuss Second Quarter 2008 Financial Results 6694 1Human Genome Sciences to Sponsor Conference Call to Discuss Second Quarter 2008 Financial Results 6694 2
...hoc analysis shows nearly nine out of ten patients... the end of 12 months, WASHINGTON, D.C., May 22, 2...I, open-label 12-14 month extension study (303),pr... (BSG) meeting,in Glasgow, Scotland in March 2007 ...rated in mild to moderate UC,patients. Today, seco...
...n Antibody Led to a Sustained Response and Remissi...nd Was Adequately,Tolerated in Patients with IV St...f., May 22, 2007 /PRNewswire-FirstCall/ -- Data,pr...g this week in,Washington D.C. by Dr. William Sand...ilizumab), an antibody in development as a,treatme...
Other Medicine Technology:Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 2Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 3Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 4Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 5Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 6Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 7Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 8PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 2PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 3PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 4PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 5
...ng system especially designed for surgical monitor...ier has 16 channels and is equipped with two headb...can be independently configured as either a true r...r amplifiers are based on the Firewire (IEEE1394TM...
...etes management software - was designed by practic...vement tool helps diabetes care providers achieve ...cine with technology by providing a state-of-the-a...rmation technology product. This diabetes softwar...
...making decisions about insulin dosages and other m...ions are guided by data from blood glucose tests a... that can be seen by you and your Health Care Prov...graphical formats. The FreeStyle CoPilot System ma...
The Ex-PRESS is a mini glaucoma shunt that provides a simplified,method of filtration surgery for patients with open angle glaucoma.,Similar to trabeculectomy, the shunt reduces the intraocular
Medicine Products: